| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| umbralisib | tyrosine-protein kinase abl1 | small molecule | NA | drugbank | Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Lymphoma Follicular[MeSHID:D008224] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Non-Hodgkin[MeSHID:D008228] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
NA | approved,investigational | inhibitor |
| umbralisib | casein kinase i epsilon | NA | Successful target | TTD , DGIDB | Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Lymphoma Follicular[MeSHID:D008224] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Non-Hodgkin[MeSHID:D008228] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
4.55 | approved | inhibitor |
| umbralisib | casein kinase i isoform epsilon | small molecule | NA | drugbank , DGIDB | Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Lymphoma Follicular[MeSHID:D008224] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Non-Hodgkin[MeSHID:D008228] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
4.55 | approved,investigational | inhibitor |
| umbralisib | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | small molecule | NA | drugbank , DGIDB | Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Lymphoma Follicular[MeSHID:D008224] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Non-Hodgkin[MeSHID:D008228] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
0.51 | approved,investigational | inhibitor |
| umbralisib | pi3-kinase delta | NA | Successful target | TTD , DGIDB | Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Lymphoma Follicular[MeSHID:D008224] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Non-Hodgkin[MeSHID:D008228] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
0.51 | approved | inhibitor |
| click here to return to the previous page | ||||||||